中国环境科学
中國環境科學
중국배경과학
China Environmental Science
2015年
9期
2853-2860
,共8页
陈默%范湛蓝%高群%高福梅%牟迪%胡建英
陳默%範湛藍%高群%高福梅%牟迪%鬍建英
진묵%범담람%고군%고복매%모적%호건영
氯代双酚A%丹酰化衍生%摄入量%等当量%LC-MS-MS
氯代雙酚A%丹酰化衍生%攝入量%等噹量%LC-MS-MS
록대쌍분A%단선화연생%섭입량%등당량%LC-MS-MS
chlorinated BPA%DNS derivatization%daily intake estimates (EDI)%toxic equivalent quantity (TEQ)%LC-MS-MS
建立了有机相丹酰化衍生-UPLC-MS-MS人体尿液样品中双酚A(BPA)及4种氯代双酚A(氯代BPA)的检测方法,对北京地区40个女性尿液样品进行了检测.结果表明:BPA 和一氯、二氯、三氯、四氯 BPA 的检出率分别为 90%、96%、90%、52%和 45%;浓度分别为(1.30±1.24),(0.40±0.37),(0.41±0.51),(0.18±1.49),(0.46±0.35) ng/mL,4种氯代BPA的总浓度为1.45ng/mL,和BPA浓度相仿.4种氯代BPA的BPA等当量浓度为4.84ng/mL,是BPA浓度的2.2倍. 40个尿液样本BPA等当量浓度符合对数正态分布,超过BPA的糖尿病发生阈值(0.05%发病风险)5.7ng/mL的概率为19.2%.人体暴露氯代BPA的健康风险应该引起重视.
建立瞭有機相丹酰化衍生-UPLC-MS-MS人體尿液樣品中雙酚A(BPA)及4種氯代雙酚A(氯代BPA)的檢測方法,對北京地區40箇女性尿液樣品進行瞭檢測.結果錶明:BPA 和一氯、二氯、三氯、四氯 BPA 的檢齣率分彆為 90%、96%、90%、52%和 45%;濃度分彆為(1.30±1.24),(0.40±0.37),(0.41±0.51),(0.18±1.49),(0.46±0.35) ng/mL,4種氯代BPA的總濃度為1.45ng/mL,和BPA濃度相倣.4種氯代BPA的BPA等噹量濃度為4.84ng/mL,是BPA濃度的2.2倍. 40箇尿液樣本BPA等噹量濃度符閤對數正態分佈,超過BPA的糖尿病髮生閾值(0.05%髮病風險)5.7ng/mL的概率為19.2%.人體暴露氯代BPA的健康風險應該引起重視.
건립료유궤상단선화연생-UPLC-MS-MS인체뇨액양품중쌍분A(BPA)급4충록대쌍분A(록대BPA)적검측방법,대북경지구40개녀성뇨액양품진행료검측.결과표명:BPA 화일록、이록、삼록、사록 BPA 적검출솔분별위 90%、96%、90%、52%화 45%;농도분별위(1.30±1.24),(0.40±0.37),(0.41±0.51),(0.18±1.49),(0.46±0.35) ng/mL,4충록대BPA적총농도위1.45ng/mL,화BPA농도상방.4충록대BPA적BPA등당량농도위4.84ng/mL,시BPA농도적2.2배. 40개뇨액양본BPA등당량농도부합대수정태분포,초과BPA적당뇨병발생역치(0.05%발병풍험)5.7ng/mL적개솔위19.2%.인체폭로록대BPA적건강풍험응해인기중시.
A derivatization UPLC-MS-MS method was used to analyze bisphenol A (BPA) and its chlorinated derivatives, including monochloro-BPA, dichloro-BPA, tricholro-BPA, and tetrachloro-BPA, in 40urine samples of Beijing women. The detection frequencies of BPA, monochloro-BPA, dichloro-BPA, tricholro-BPA, and tetrachloro-BPA were 90%, 96%, 90%, 52%, and 45% with average concentrations of (1.30±1.24), (0.40±0.37), (0.41±0.51), (0.18±1.49), (0.46±0.35) ng/mL, respectively. While the total concentration of four chlorinated BPA was 1.45ng/mL, which was similar with that of BPA in urine, their BPA toxic equivalent quantity (TEQBaP) in urine was calculated to be 4.84ng/mL, which was 2.2 fold higher than that of BPA. The TEQBPA concentration was log-normally distributed, and the probability higher than Benchmark Dose (BMDL0.05), corresponding to the increasing risk of diabetes by 0.05% due to exposure to BPA, was 19.2%. Our results indicated that chlorinated BPA might pose a relatively high risk.